Literature DB >> 7651735

Loss of heterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinomas.

S Casola1, P Ungaro, P V Pedone, D Lazzaro, E Fattori, G Ciliberto, R Zarrilli, C B Bruni, A Riccio.   

Abstract

Expression of the chromosomally linked Insulin-like Growth Factor II (IGF-II) and H19 genes is regulated by parental imprinting during development, since the maternally inherited IGF-II and the paternally inherited H19 alleles are inactive in fetal tissues. Here we show that expression of IGF-II and H19 genes is activated in transgenic mice during SV40 Tag-induced hepatocarcinogenesis and that imprinting of both genes is conserved in the liver tumors. Allelic imbalances of IGF-II and H19 genes and other chromosome 7 markers were detected in one third (13/39) of the hepatocellular carcinomas analysed. A strong bias on the allele retained in the neoplasms was observed, since underrepresentation or complete loss of maternal chromosome 7 was recognised in 12/13 cases. High levels of IGF-II mRNA were expressed by all carcinomas with relative excess of paternal chromosome 7 alleles and suppressed H19 expression was found in the neoplasms lacking the maternal alleles. Overall the results indicate that expression of imprinted genes is involved in progression of experimental liver tumors and suggest that the murine chromosome 7, whose loss may possibly cause the inactivation of a growth-inhibitory gene, is preferentially retained as paternal copy in the liver tumors because of parental imprinting of IGF-II gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7651735

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

Review 1.  Mechanisms of transcriptional regulation of cellular genes by SV40 large T- and small T-antigens.

Authors:  U Moens; O M Seternes; B Johansen; O P Rekvig
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

Review 2.  The IGF axis and hepatocarcinogenesis.

Authors:  J G Scharf; F Dombrowski; G Ramadori
Journal:  Mol Pathol       Date:  2001-06

3.  Nonrandom cytogenetic alterations in hepatocellular carcinoma from transgenic mice overexpressing c-Myc and transforming growth factor-alpha in the liver.

Authors:  L M Sargent; X Zhou; C L Keck; N D Sanderson; D B Zimonjic; N C Popescu; S S Thorgeirsson
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

4.  Imprinted H19 oncofetal RNA is a candidate tumour marker for hepatocellular carcinoma.

Authors:  I Ariel; H Q Miao; X R Ji; T Schneider; D Roll; N de Groot; A Hochberg; S Ayesh
Journal:  Mol Pathol       Date:  1998-02

5.  The H19 locus acts in vivo as a tumor suppressor.

Authors:  Tomomi Yoshimizu; Audrey Miroglio; Marie-Anne Ripoche; Anne Gabory; Maria Vernucci; Andrea Riccio; Sabine Colnot; Cécile Godard; Benoit Terris; Hélène Jammes; Luisa Dandolo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

6.  SV40 Tag DNA sequences, present in a small proportion of human hepatocellular carcinomas, are associated with reduced survival.

Authors:  N A C S Wong; F Rae; M M Herriot; N J Mayer; D H Brewster; D J Harrison
Journal:  J Clin Pathol       Date:  2003-12       Impact factor: 3.411

Review 7.  Targeting insulin-like growth factor axis in hepatocellular carcinoma.

Authors:  Jennifer Wu; Andrew X Zhu
Journal:  J Hematol Oncol       Date:  2011-07-05       Impact factor: 17.388

8.  Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1.

Authors:  D C Martin; J L Fowlkes; B Babic; R Khokha
Journal:  J Cell Biol       Date:  1999-08-23       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.